Skip to main content
Figure 8 | BMC Cancer

Figure 8

From: Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer

Figure 8

NF-κB DNA binding activity in DHMEQ 3 μg/ml, paclitaxel 10nM, or their combination treatment. Proteins were separately extracted from the cytoplasm and nucleus of each treated T24PR cells after the treatment of DHMEQ 3 μg/ml, paclitaxel 10nM, or their combination. 2 μl nuclear extract (at a concentration of 2 μg/μl) mixed with biotin-labeled NF-κB probe for EMSA assay was used.

Back to article page